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Background: The NLR family, pyrin domain-containing 3 (NLRP3) inflammasome plays a key role in intracerebral
hemorrhage (ICH)-induced inflammatory injury, and the purinergic 2X7 receptor (P2X7R) is upstream of NLRP3
activation. This study aimed to investigate how P2X7R functions in ICH-induced inflammatory injury and how the
receptor interacts with the NLRP3 inflammasome.
Methods: Rats were treated with P2X7R small interfering RNA (siRNA) 24 h before undergoing collagenase-induced
ICH. A selective P2X7R inhibitor (blue brilliant G, BBG) or a peroxynitrite (ONOO−) decomposition catalyst
(5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron(III) [FeTPPS]) was injected 30 min after ICH. Brain water
content, hemorrhagic lesion volume, and neurological deficits were evaluated, and western blot, immunofluorescence,
and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) were carried out.
Results: Striatal P2X7R and NLRP3 inflammasomes were activated after ICH. Gene silencing of P2X7R suppressed
NLRP3 inflammasome activation and interleukin (IL)-1β/IL-18 release and significantly ameliorated brain edema and
neurological deficits. Additionally, enhanced NADPH oxidase 2 (NOX2, gp91phox) and inducible nitric oxide synthase
(iNOS), as well as their cytotoxic product (ONOO−) were markedly attenuated by BBG treatment following ICH. This was
accompanied by downregulations of the inflammasome components, IL-1β/IL-18 and myeloperoxidase (MPO, a
neutrophil marker). Most importantly, inflammasome activation and IL-1β/IL-18 release were significantly inhibited by
ONOO− decomposition with FeTPPS.
Conclusions: Our findings implicate that P2X7R exacerbated inflammatory progression and brain damage in ICH rats
possibly via NLRP3 inflammasome-dependent IL-1β/IL-18 release and neutrophil infiltration. ONOO−, a potential
downstream signaling molecule of P2X7R, may play a critical role in triggering NLRP3 inflammasome activation.
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Spontaneous intracerebral hemorrhage (ICH) is a devas-
tating stroke subtype, with high morbidity and mortality
[1]. Unfortunately, no satisfactory pharmacologic treat-
ments have been found for clinical practice, mainly due to
a lack of knowledge underlying the mechanisms of post-* Correspondence: yizhao_chen@hotmail.com
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(http://creativecommons.org/publicdomain/zeICH brain damage. There is an urgent need to clarify the
pathophysiology of this disease to identify effective
therapies.
Accumulating evidence suggests that innate immunity
and inflammatory responses are involved in ICH-induced
secondary brain injury [1–3]. The intracellular Nod-like
receptors have recently been shown to play a critical role
in the process of innate immunity and inflammatory
responses [4]. The NLR family, pyrin domain-containing 3
(NLRP3) inflammasome, the best characterized member
of Nod-like receptor family, is a multiprotein complex thats distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Feng et al. Journal of Neuroinflammation  (2015) 12:190 Page 2 of 17contains the adaptor protein apoptosis-associated speck-
like protein containing a CARD (ASC) and the effector
caspase-1. Once activated, caspase-1 can cleave the pro
forms of interleukin (IL)-1β and IL-18 into their mature
and active forms, which leads to the recruitment and acti-
vation of other immune cells, such as neutrophils [5]. In
this regard, evidence indicates that the NLRP3 inflamma-
some plays a pivotal role in ICH [2] and other central ner-
vous system (CNS) conditions [6–11], but the precise
mechanisms associated with inflammasome activation
continue to be debated.
The role of ATP-gated transmembrane cation channel
P2X7R in the signaling cascade has received particular
attention due to its widespread involvement as a key
regulatory element of NLRP3 inflammasome activation
[12]. A growing number of studies have demonstrated
the important pathophysiological functions of P2X7R in
CNS disorders, including ischemic stroke, subarachnoid
hemorrhage, neurotrauma, epilepsy, neuropathic pain,
and neurodegenerative illnesses [13, 14]. However, the
specific role of P2X7R in ICH has not yet been estab-
lished, and the interaction between P2X7R and the
NLRP3 inflammasome in the development of ICH-
induced brain injury remains unclear.Fig. 1 Expression profile of P2X7R and its cellular location after collage
(a) for the time course of P2X7R expression in the ipsilateral hemisphere of Sh
shown, n = 4 rats per group and time point. Confocal images (c) of double im
following ICH, n = 6 rats per group. Scale bar = 12.5 μm. Data represent mean
3-phosphate dehydrogenase, ICH intracerebral hemorrhageIn the case of ICH, both NADPH oxidase 2 (NOX2) and
inducible nitric oxide synthase (iNOS) have been reported
to contribute to brain injury; knockout mice exhibit less
brain edema and cell death than wild-type controls follow-
ing ICH [15, 16]. Superoxide anion (O2
−) and nitric oxide
(NO), released through NOX and iNOS in activated
microglia, act as devastating pro-inflammatory mediators
in CNS diseases [17]. More importantly, peroxynitrite
(ONOO−), the product of a diffusion-controlled reaction
of NO with O2
−, is a more potent oxidant species and is
involved in the pathologies of ischemic stroke, neuro-
trauma, and neurodegenerative diseases [18–20]. We pre-
viously demonstrated that abundant ONOO− formed in a
hemoglobin (Hb)-induced ICH rat model [21], but the
exact mechanisms of ONOO− in brain injury after ICH
have not been fully characterized. Besides its ability to
oxidize or nitrate proteins, lipids, and DNA, ONOO− can
also lead to destructive pathological consequences by trig-
gering the activation of several biochemical pathways en-
gaged in the development of neuroinflammation and IL-
1β production [22–24]. However, the precise link between
ONOO− formation and IL-1β secretion in ICH is unclear.
The P2X7R acts as an upstream molecule of NOX2
activation signaling in many in vivo and in vitro diseasenase-induced intracerebral hemorrhage (ICH). Western blot analysis
am and ICH rats within 72 h. Quantification of P2X7R (b) expression is
munofluorescence for P2X7R expression in Iba-1-positive microglia 24 h
s ± SD. *P < 0.05 vs. Sham, **P < 0.01 vs. Sham. GAPDH glyceraldehyde
Feng et al. Journal of Neuroinflammation  (2015) 12:190 Page 3 of 17models [25–27]. NOX2-mediated oxidative stress was re-
cently proposed to be responsible for activation of the
NLRP3 inflammasome and subsequent neurovascular
damage in ischemic stroke [7]. Notably, P2X7R-dependent
NADPH oxidase activation and ONOO− formation play
key roles in caspase-1 and IL-1β processing in endotoxin-
primed human monocytes [28]. In an animal model of
lipopolysaccharide (LPS)-induced striatum injury, acti-
vated P2X7R in microglia was associated with increased
iNOS and 3-nitrotyrosine (3-NT, a reliable marker of
ONOO−), and this was reversed by the P2X7R antagonist
oxidized ATP (oxATP) [29]. Despite this knowledge, the
potential roles of P2X7R and NLRP3 inflammasomes and
NOX2/iNOS-dependent ONOO− formation in the devel-
opment of ICH-induced brain damage remain to be
clarified.
We hypothesized that ONOO−, formed from NOX2-
derived O2
− and iNOS-derived NO, may be involved in
transducing P2X7R-mediated IL-1β/IL-18 production and
brain injury via NLRP3 inflammasome activation after
ICH. We first investigated the expression profiles of
P2X7R and the NLRP3 inflammasome components. Next,
a mixed small interfering (si) RNA was applied to knock
down P2X7R in vivo, and alterations in NLRP3 inflamma-
some components and functional outcomes were mea-
sured. We then explored the therapeutic effect of the
selective P2X7R antagonist, blue brilliant G (BBG). Add-
itionally, we observed iNOS- and NOX2-dependent for-
mation of ONOO− and their alterations in ICH rats
following BBG treatment. Finally, to determine whetherFig. 2 Expression profiles of NLRP3, ASC, and caspase-1 p20 subunit a
of NLRP3 (b), ASC (c), and caspase-1 p20 subunit (d) in the ipsilatera
NLRP3, ASC, and caspase-1 p20 subunit expression is shown, respectively, n =
vs. Sham, **P < 0.01 vs. Sham. ASC adaptor protein apoptosis-associated speck
dehydrogenase, ICH intracerebral hemorrhage, NLRP3 pyrin domain-containinONOO− is involved in P2X7R-mediated NLRP3 inflam-
masome activation, we used an ONOO− decomposition
catalyst in vivo and measured the expression levels of
P2X7R and NLRP3 inflammasome components.Materials and methods
Animals
Sprague–Dawley (SD) male rats weighing 280–320 g
were purchased from the Animal Experiment Center of
Southern Medical University (Guangzhou, China). All
experimental procedures and animal care were approved
by the Southern Medical University Ethics Committee.ICH model
After anesthetization (0.3 ml/100 g, 10 % chloral hy-
drate, Sigma-Aldrich, St. Louis, MO, USA), an incision
was made on the skin along the sagittal midline to ex-
pose the skull. A burr hole (1 mm) was drilled 3 mm lat-
eral and 1 mm anterior to the bregma, then a 30-gauge
needle was inserted through the burr hole into the stri-
atum (6 mm ventral from the skull surface), and ICH
was induced by stereotaxic infusion of bacterial collage-
nase VII-S (0.25U in 1.0 μl sterile saline, Sigma-Aldrich)
over a 10-min period. In the Sham group, rats were sub-
jected to only a needle insertion as described above. The
needle was kept in situ for another 10 min to prevent
backflow and then slowly removed. The craniotomies
were sealed with bone wax. Rats were allowed to recover
in separate cages with free access to food and water.fter ICH. Western blot analysis (a) for the time course expressions
l hemisphere of Sham and ICH rats within 72 h. Quantification of
4 rats per group and time point. Data represent means ± SD. *P < 0.05
-like protein containing a CARD, GAPDH glyceraldehyde 3-phosphate
g 3
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Four separate experiments were conducted as shown in
Additional file 1.
Experiment 1
Thirty-six rats were divided into six groups (Sham, and
6, 12, 24, 48, and 72 h after ICH). The expression levels
of P2X7R, NLRP3, ASC, and caspase-1 were detected by
western blot. The tissue for immunofluorescence (IF)
was collected 24 h after ICH induction.
Experiment 2
Eighty-eight rats were randomized into four groups:
Sham, Vehicle (ICH + saline, intracerebroventricular in-
jection), Scramble small interfering RNA (siRNA) (1000
pmol, 2 μl, ICH + scramble siRNA), and P2X7R siRNA
(1000 pmol, 2 μl, ICH + P2X7R siRNA). siRNA silencing
efficacy was assessed by western blot. Brain water con-
tent and modified Neurological Severity Score (mNSS)
were also measured.
Experiment 3
One hundred and thirty-two rats were randomized into
four groups: Sham, Vehicle (ICH + saline, intraperitoneal
injection), BBG (50 mg/kg), and BBG (100 mg/kg). ForFig. 3 Effects of P2X7R small interfering RNA (siRNA) treatment in ICH rats.
per group (a). Western blot assay and quantification of P2X7R (b) after siRNA
h after ICH, n = 6 rats per group. mNSS (d) at 24 and 72 h after ICH, n = 6 rats
Vehicle, #P < 0.05 vs. ICH + Scramble siRNA. GAPDH glyceraldehyde 3-phosph
small interfering RNAthe 72-h study, BBG was administered daily by intraperi-
toneal injection. Western blot, hematoxylin and eosin
(H&E) staining, immunofluorescence (IF), and terminal
deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) were measured 24 h after ICH induction;
mNSS and brain water content were detected at both 24
and 72 h.
Experiment 4
Thirty-three rats were randomized into three groups:
Sham, Vehicle (ICH + saline, intraperitoneal injection),
and FeTPPS (30 mg/kg). Western blotting was performed
24 h after ICH induction.
siRNA and drug delivery
BBG (Sigma-Aldrich) was diluted at 50 and 100 mg/kg
in Vehicle (saline) solution. Rats were treated intraperi-
toneally with either BBG or Vehicle immediately after
ICH induction and at 12, 36, and 60 h.
For in vivo siRNA administration, P2X7R siRNA or
non-silencing RNA (Sigma-Aldrich) was applied 24 h
before ICH by intracerebroventricular injection as previ-
ously described [2]. A cranial burr hole (1 mm) was
drilled, and a 30-gauge needle was inserted stereotaxic-
ally into the right lateral ventricle. To improve the geneRT-PCR of P2X7R after siRNA treatment 24 h following ICH, n = 6 rats
treatment 24 h following ICH, n = 4 rats per group. Brain edema (c) at 24
per group. Data represent means ± SD. **P < 0.01 vs. Sham, @P < 0.05 vs.
ate dehydrogenase, mNSS modified Neurological Severity Score, siRNA
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G-3′. siRNA was dissolved in RNA free water. Scrambled
control siRNA (1000 pmol, 2 μl), P2X7R siRNA (1000
pmol, 2 μl), or RNA free water (2 μl) was delivered intra-
cerebroventricularly for 2 min. The needle was left in
place for an additional 10 min after injection and then
slowly withdrawn.
FeTPPS (Millipore, Billerica, MA, USA) was diluted
to 30 mg/kg in Vehicle (saline) solution. Rats were
treated intraperitoneally with either FeTPPS or Vehicle
immediately and at 12 h after ICH induction. The
FeTPPS dose was selected based on our previous re-
ports that showed that it is effectively protected against
injury [30].Fig. 4 Effects of P2X7R siRNA on NLRP3 inflammasome activation and I
treatment 24 h following ICH (a), n = 6 rats per group. Western blot a
subunit (e), IL-1β (f), and IL-18 (g) after P2X7R siRNA treatment 24 h fo
**P < 0.01 vs. Sham, @P < 0.05 vs. Vehicle, #P < 0.05 vs. ICH + Scramb
protein containing a CARD, GAPDH glyceraldehyde 3-phosphate dehy
NLR family, pyrin domain-containing 3RT-PCR
Rats were anesthetized and decapitated. Lesioned tissues
(about 40 mg) were obtained, and total RNA was ex-
tracted from the tissue with GeneJET™ RNA Purification
Kit (Thermo Fisher Scientific Inc., Waltham, MA, USA).
RNA (1 μg) was reverse-transcribed to cDNA with high
capacity (Life Technologies, Carlsbad, CA, USA). RT-PCR
was performed in an ABI Prism 7500 sequence detection
system (Applied Biosystems, Foster City, CA, USA) using
specific primers designed from known sequences. GAPDH
was used as an endogenous control gene. Sequence-






NLRP3, 5′-CTGCATGCCGTATCTGGTTG-3′L-1β/IL-18 maturation after ICH. RT-PCR of NLRP3 after P2X7R siRNA
ssay (b) and quantification of NLRP3 (c), ASC (d), caspase-1 p20
llowing ICH, n = 4 rats per group. Data represent means ± SD.
le siRNA. ASC adaptor protein apoptosis-associated speck-like
drogenase, ICH intracerebral hemorrhage, IL interleukin, NLRP3 The






(reverse primer);Fig. 5 Effects of BBG on brain edema in ICH rats. BBG treatment evidently
and eosin (H&E) showed the hemorrhagic lesion volume alteration after BB
damage after BBG treatment at 24 (c) and at 72 h (g) following ICH. n = 6
brilliant blue G, ICH intracerebral hemorrhageWestern blot
Western blotting was performed as described previously
[30]. The following primary antibodies were used: rabbit
polyclonal anti-P2X7R (1:1000, Alomone Labs, Jerusalem,
Israel), rabbit polyclonal anti-NLRP3 antibody (1:1000,
Santa Cruz, Biotechnology, Santa Cruz, CA, USA), rabbit
polyclonal anti-ASC antibody (1:500, Abclonal, Cambridge,reduced brain edema at 24 (d) and at 72 h (h) after ICH. Hematoxylin
G treatment at 24 (a, b) and at 72 h (e, f) following ICH. Tissue
rats per group. Data represent means ± SD. *P < 0.05, **P < 0.01. BBG
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(1:1000, Santa Cruz Biotechnology), rabbit polyclonal anti-
IL-1β antibody (1:1000, Millipore), rabbit monoclonal anti-
IL-18 antibody (1:1000, Abcam, Cambridge, UK), mouse
monoclonal anti-nitrotyrosine antibody (1:1000, Abcam),
mouse monoclonal anti-iNOS antibody (1:200, Santa Cruz
Biotechnology), mouse monoclonal anti-gp91phox antibody
(1:2000, BD Transduction Laboratories, San Jose, CA,
USA), and rabbit polyclonal anti-myeloperoxidase antibody
(MPO, 1:500, Abcam). GAPDH (1:1000, Cell Signaling
Technology, Danvers, MA, USA) was employed as the
loading control. Blot bands were quantified by densitometry
with ImageJ software (National Institutes of Health,
Baltimore, MD, USA).
Paraffin section preparations
The sections were processed as previously described [30]
with minor modifications. After anesthetization, rats
were transcardially perfused with 200 ml saline followed
by 400 ml 4 % paraformaldehyde solution. Brain tissues
were then removed and fixed by immersion in the same
solution at 4 °C for 24 h. After dehydration andFig. 6 Effects of BBG on neuronal apoptosis and neurological outcomes in
(a, b) 24 h following ICH, n = 6 rats per group. BBG significantly improved
group. Scale bar = 50 μm. Data represent means ± SD. *P < 0.05, **P < 0.01vitrification, they were embedded in paraffin, and 3-μm
sections were prepared. Sections were dewaxed, rehy-
drated, and then processed for IF and TUNEL.
Histological examination
Coronal sections (1 mm apart) [31] were prepared accord-
ingly and then stained with H&E. Hemorrhagic volumes
were calculated using Image Pro Plus 6.0 software (Media
Cybernetics, USA) to span the entire hematoma [32].
IF
Antigen retrieval was performed by heat treatment in a
microwave oven for 21 min in Tris–EDTA buffer solu-
tion (0.05 mol/L Tris, 0.001 mol/L EDTA; pH 8.5).
Sections were incubated for 30 min in 5 % bovine serum
albumin (BSA) and then incubated at 4 °C overnight
with primary antibodies (rabbit polyclonal anti-P2X7R,
1:500, Alomone labs; mouse monoclonal anti-3-
Nitrotyrosine, 1:400, Abcam; rabbit polyclonal anti-
nitrotyrosine antibody, 1:200, Millipore; rabbit polyclonal
anti-MPO antibody, 1:50, Abcam; rabbit polyclonal anti-
iNOS antibody, 1:40, Santa Cruz Biotechnology; rabbitICH rats. BBG significantly reduced the number of apoptotic neurons
neurological deficits (c) at 24 and at 72 h after ICH, n = 6 rats per
. BBG brilliant blue G
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Japan; goat polyclonal anti-Iba-1 antibody, 1:300, Abcam;
mouse monoclonal gp91phox antibody, 1:400, BD Trans-
duction Laboratories). For double-staining experiments,
primary antibodies were separately incubated overnight
at 4 °C. After they were washed with phosphate-buffered
saline (PBS), sections were then incubated with second-
ary antibodies. Images were obtained using confocal mi-
croscopes (FV10i-W, Olympus, Tokyo, Japan; LSM780,
Zeiss, Oberkochen, Germany).TUNEL
At 24 h after ICH, TUNEL staining was performed with
an in situ apoptosis detection kit (Roche, Basel,
Switzerland) according to the manufacturer’s instruction.
For NeuN and TUNEL co-staining, the sections were
first labeled with a NeuN antibody (1:400, Abcam),
followed by TUNEL. The slides were analyzed using a
fluorescence microscope (Bx51, Olympus).Fig. 7 Effects of BBG on NLRP3 inflammasome activation and IL-1β/IL-1
ICH, n = 6 rats per group (a). Representative western blot (b) and ther
p20 subunit (f), mature IL-1β (g), and mature IL-18 (h) levels in the ips
represent means ± SD. *P < 0.05, **P < 0.01. ASC adaptor protein apop
blue G, GAPDH glyceraldehyde 3-phosphate dehydrogenase, ICH intraceBrain water content measurement
Brain edema was evaluated by a common wet/dry
method as previously described [33]. Briefly, at 24 or 72
h post-ICH, rats were anesthetized and decapitated. The
brains were removed and immediately separated into
contralateral and ipsilateral hemispheres and the cere-
bellum and wet weighed. The cerebellum was used as an
internal control. Brain specimens were dried in an oven
at 100 °C for 24 h to obtain the dry weight. The water
content was expressed as a percentage of the wet weight:
([wet weight] – [dry weight]) / (wet weight) × 100 %.
Behavioral testing
Behavioral tests were assessed with mNSS at 24 and 72
h after ICH by an investigator who was blinded to the
experimental groups [34].
Statistical analysis
Data are shown as mean ± SD. Statistical analysis was
performed using SPSS 13.0 (SPSS Inc., Chicago, IL, USA).8 maturation. RT-PCR of NLRP3 after BBG treatment 24 h following
apeutic effects of BBG on P2X7R (c), NLRP3 (d), ASC (e), caspase-1
ilateral hemisphere 24 h after ICH, n = 4 rats per group. Data
tosis-associated speck-like protein containing a CARD, BBG brilliant
rebral hemorrhage, IL interleukin, NLRP3 pyrin domain-containing 3
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tests or one-way analysis of variance (ANOVA) followed by
least significant difference (LSD) tests with multiple compari-
sons. The statistically significant level was P < 0.05.
Results
P2X7R was increased and mainly expressed in microglia
cells following ICH
Protein content was analyzed at different time points
after injection to investigate whether P2X7R would re-
spond to collagenase-induced ICH. As shown by western
blot (Fig. 1a, b), P2X7R levels were significantly elevated
at 6 h after ICH (P < 0.05 vs. Sham) and peaked at
around 24 h (P < 0.01 vs. Sham) when P2X7R levels were
nearly 4.5 times more than those in the Sham group.
Following the peak, P2X7R levels decreased, returning
close to baseline levels at 72 h.
Double immunolabeling was performed to identify the
cell type that expresses P2X7R. The results showed that
P2X7R was predominantly expressed in microglia cells
(Fig. 1c) and not in other cell types, such as astrocytes or
neurons (Additional file 2).
NLRP3, ASC, and caspase-1 were upregulated after ICH
NLRP3 inflammasome has been proposed to be downstream
of P2X7R [12]. We evaluated the expressions of NLRP3
inflammasome components by western blot (Fig. 2a). NLRP3
(Fig. 2b), ASC (Fig. 2c), and cleaved caspase-1 (Fig. 2d) were
significantly upregulated at 6 h (P < 0.05 vs. Sham) and
reached their peak at 24 h post-ICH (P < 0.01 vs. Sham).
Following this peak, levels of all three proteins declinedFig. 8 Effects of BBG on neutrophils infiltration after ICH. Representative ph
marker)-positive cells in perihematomal area in the Sham, Vehicle, and BBG
Representative western blot (b) and effects of BBG on MPO levels (c) at 24
means ± SD. *P < 0.05, **P < 0.01. BBG brilliant blue G, ICH intracerebral hembut still remained higher than those in the Sham group at
48 h (P < 0.05 vs. Sham) and 72 h (P < 0.05 vs. Sham).
P2X7R RNA interference reduced brain water content and
improved neurological outcomes
We next explored whether P2X7R is involved in brain injury
following ICH. Two P2X7R siRNA mixtures were applied 24
h before ICH induction. Silencing efficacy by RT-PCR dem-
onstrated a significant inhibitory effect of P2X7R siRNA on
its mRNA levels (P < 0.01) (Fig. 3a). Western blot (Fig. 3b)
showed 41.3 and 40.7 % reductions of P2X7R in the P2X7R
siRNA group compared with the Vehicle and Scramble
siRNA groups, respectively (both P < 0.05), at 24 h after ICH.
Brain water content in the ipsilateral hemisphere was signifi-
cantly increased in the Vehicle (82.56 ± 0.72 % vs. Sham,
79.40 ± 0.44 %, P < 0.01) and Scramble siRNA (82.44 ± 0.75
% vs. Sham, 79.40 ± 0.44 %, P < 0.01) groups at 24 h post-
ICH, while that in P2X7R siRNA group was decreased to
81.39 ± 0.58 % (P < 0.05 vs. Vehicle or Scramble siRNA)
(Fig. 3c). Consistent with the brain edema results, P2X7R
siRNA administration significantly ameliorated neurological
deficits at 24 h (8.66 ± 1.15 vs. Vehicle, 10.00 ± 1.95,
P < 0.05; vs. Scramble siRNA, 10.50 ± 1.26, P < 0.05) and
72 h (6.33 ± 0.81 vs. Vehicle, 8.10 ± 1.96, P < 0.05; vs. Scram-
ble siRNA, 8.16 ± 1.16, P < 0.05) post-ICH (Fig. 3d).
P2X7R RNA interference inhibited NLRP3 inflammasome
activation and subsequent IL-1β/IL-18 release
NLRP3 inflammasome is actively involved in brain injury
after ICH [2]. We further clarify the role of P2X7R in
NLRP3/ASC/caspase-1 activation and the subsequentotographs of immunofluorescence staining (a) for MPO (neutrophil
(50 mg/kg) groups at 24 h following operation, n = 6 rats per group.
h after ICH, n = 4 rats per group. Scale bar = 50 μm. Data represent
orrhage
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nificantly reduced NLRP3 mRNA expression (P < 0.01)
(Fig. 4a). The protein levels of NLRP3 inflammasome
component and IL-1β/IL-18 production were evidently el-
evated in the Vehicle and Scramble siRNA groups at 24 h
after ICH (P < 0.01). P2X7R siRNA treatment significantly
suppressed caspase-1 activation and the subsequent secre-
tion of mature IL-1β/IL-18 (P < 0.05) (Fig. 4b–f ).
BBG deceased post-ICH neurological deficits, brain water
content, and neuronal apoptosis
Next, we investigated the effects of the selective P2X7R
inhibitor, BBG. Both doses (50 and 100 mg/kg) significantly
attenuated brain water content at 24 h (50 mg/kg, 81.76 ±
0.32 % vs. Vehicle, 82.54 ± 0.66 %, P < 0.05; 100 mg/kg,
81.67 ± 0.43 % vs. Vehicle, 82.54 ± 0.66 %, P < 0.05) and 72
h (50 mg/kg, 81.59 ± 1.15 % vs. Vehicle, 82.94 ± 1.00 %, P
< 0.05; 100 mg/kg, 81.74 ± 1.12 % vs. Vehicle, 82.94 ± 1.00
%, P < 0.05) after ICH (Fig. 5d, h). The hemorrhagic lesion
volume at 24 h post-ICH for the Vehicle and BBG groups
were 91.17 ± 23.54 and 82.77 ± 21.31, respectively
(P > 0.05) (Fig. 5a, b), indicating that BBG did not affect
bleeding. However, the hemorrhagic lesion volume for the
BBG group (37.79 + 15.56) was significantly decreased
compared with the Vehicle (73.03 + 19.34) group at 72 hFig. 9 Effects of BBG on ICH-induced iNOS expression in the striatum. Mos
(b, c) and immunofluorescence labeling (d) showing that BBG treatment si
with the Vehicle group. n = 4 (b, c) or n = 6 (a, d) rats per group. Scale bar =
BBG brilliant blue G, GAPDH glyceraldehyde 3-phosphate dehydrogenase, ICHpost-ICH (P < 0.01) (Fig. 5e, f ), indicating that BBG could
promote tissue reconstruction. Meanwhile, the tissue
damage around the lesion site was evidently mitigated by
BBG treatment at both 24 and 72 h (Fig. 5c, d, g, h). Con-
sistently, neurological deficits (Fig. 6c) at both 24 h (50 mg/
kg, 8.83 ± 1.64 vs. Vehicle, 10.00 ± 1.95, P < 0.05; 100 mg/
kg, 8.66 ± 1.55 vs. Vehicle, 10.00 ± 1.95, P < 0.05) and 72 h
(50 mg/kg, 6.40 ± 1.64 vs. Vehicle, 8.10 ± 1.96, P < 0.05;
100 mg/kg, 7.00 ± 1.78 vs. Vehicle, 8.10 ± 1.96, P < 0.05)
after ICH were improved by BBG treatment. However,
there was no difference between animals that received 50
and 100 mg/kg doses of BBG treatment with regard to
mNSS scores or brain water contents. Thus, the 50 mg/kg
dose was applied in further studies.
The number of apoptotic neurons was significantly in-
creased at 24 h after ICH compared with the Sham
group (P < 0.01), and BBG treatment significantly re-
duced the number of apoptotic neurons (P < 0.01) rela-
tive to the Vehicle group (Fig. 6a, b).
BBG decreased P2X7R expression, NLRP3/ASC/caspase-1
activation, and subsequent IL-1β/IL-18 production following
ICH
BBG treatment significantly reduced NLRP3 mRNA
levels (Fig. 7a). Western blot analysis revealed that BBGt iNOS signals overlapped with Iba-1 positive microglia (a). Western blot
gnificantly decreased striatal iNOS expression 24 h after ICH compared
25 μm (a) or 50 μm (d). Data represent means ± SD. *P < 0.05, **P < 0.01.
intracerebral hemorrhage, iNOS inducible nitric oxide synthase
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P2X7R (P < 0.05 vs. Vehicle), NLRP3 (P < 0.05 vs. Ve-
hicle), ASC (P < 0.01 vs. Vehicle), and cleaved caspase-1
(P < 0.05 vs. Vehicle). Furthermore, the levels of mature
IL-1β (P < 0.05 vs. Vehicle) and IL-18 (P < 0.05 vs. Vehicle)
were distinctly reduced after BBG treatment (Fig. 7b–h).BBG reduced neutrophils infiltration after ICH.
We detected MPO levels in brain tissue by IF (Fig. 8a)
and western blot (Fig. 8b, c) at 24 h following ICH
to determine the effect of P2X7R/NLRP3 inflamma-
some axis activation on neutrophil infiltration. Striatal
MPO levels were evidently increased following ICHFig. 10 Effects of BBG on ICH-induced gp91phox expression in the striatum
overlapped with iNOS (b). Western blot (c, d) and immunofluorescence lab
gp91phox expression 24 h after ICH compared with the Vehicle group. n =
50 μm (e). Data represent means ± SD. *P < 0.05; **P < 0.01. BBG brilliant blue
hemorrhage, iNOS inducible nitric oxide synthasecompared with the Sham group (P < 0.01 vs. Sham).
BBG (50 mg/kg) significantly suppressed MPO ex-
pression compared to the Vehicle group (P < 0.05 vs.
Vehicle).
BBG suppressed ICH-induced iNOS expression
iNOS is upregulated in both blood infusion and collagenase-
induced ICH rat models [31, 35]. The role of P2X7R in
iNOS signaling was next investigated using IF and western
blot analysis. iNOS expression was weak in Sham-operated
rats but was dramatically elevated 24 h after ICH induction
(P < 0.01 vs. Sham). To further trace the source of iNOS,
double IF was performed and found that iNOS was mainly
expressed in Iba-1-positive microglia (Fig. 9a). Western. Gp91phox significantly colocalized with Iba-1 (a). Most gp91phox signals
eling (e) showing that BBG treatment significantly reduced the striatal
4 (d) or n = 6 (e) rats per group. Scale bar = 20 μm (a) or 25 μm (b) or
G, GAPDH glyceraldehyde 3-phosphate dehydrogenase, ICH intracerebral
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markedly attenuated in BBG-treated rats (P < 0.05 vs. Ve-
hicle) (Fig. 9b–d).
BBG reduced ICH-induced NOX2 expression
NOX2, a primary source of O2
−, is actively involved in
ICH-induced brain injury [15]. We studied the expression
of gp91phox, a membrane subunit of NOX2, by IF and
western blotting. Double IF showed that gp91phox was also
mainly expressed in Iba-1-positive areas (Fig. 10a) and
most overlapped with iNOS expression (Fig. 10b), imply-
ing a close connection between them. Consistent with
iNOS, gp91phox was significantly increased after ICH in ip-
silateral hemisphere brain tissues as compared with the
Sham group (P < 0.01 vs. Sham) at 24 h after ICH. BBG
treatment significantly downregulated gp91phox overex-
pression (P < 0.05 vs. Vehicle) (Fig. 10c–e).Fig. 11 Effects of BBG on ICH-induced 3-NT expression in the striatum. 3-N
with gp91phox (b). Western blot (c, d) and immunofluorescence staining (e
expression 24 h after ICH compared with the Vehicle group. n = 4 (a, b, e)
represent means ± SD. *P < 0.05, **P < 0.01. BBG brilliant blue G, GAPDH gly
hemorrhage, 3-NT 3-nitrotyrosineBBG attenuated peroxynitrite formation following ICH
The enhancement of iNOS and NOX2 after ICH induction
prompted us to examine the involvement of P2X7R in
ONOO− formation. Double IF demonstrated a high degree
of colocalization with Iba-1 (Fig. 11a). Moreover, 3-NT and
gp91phox expressions were almost completely overlapped
(Fig. 11b), implying that peroxynitrite production is NOX2
dependent. However, BBG treatment significantly down-
regulated 3-NT overexpression (P < 0.05 vs. Vehicle)
(Fig. 11c–e).
The ONOO− decomposition catalyst FeTPPS inhibited
NLRP3/ASC/Caspase-1 activation and subsequent
production of mature IL-1β/IL-18 following ICH
Our findings suggested a pivotal role for microglia-
expressed P2X7R in mediating ONOO− formation in an
iNOS and NOX2-dependent way, which further promptedT significantly colocalized with Iba-1 (a). Most 3-NT signals overlapped
) showing that BBG treatment significantly suppressed striatal 3-NT
or n = 6 (c, d) rats per group. Bar = 12.5 μm (a, b) or 50 μm (e). Data
ceraldehyde 3-phosphate dehydrogenase, ICH intracerebral
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between P2X7R and NLRP3 inflammasome activation. To
answer this question, the ONOO− decomposition catalyst
FeTPPS was applied in vivo. Firstly, FeTPPS significantly
reduced 3-NT levels (P < 0.01 vs. Vehicle) on western blot
(Fig. 12a, b). Thereafter, the expression levels of P2X7R
and NLRP3 inflammasome components were measured by
western blot at 24 h following ICH. The results indicated
that FeTPPS significantly downregulated the enhanced
levels of NLRP3 (P < 0.05 vs. Vehicle), ASC (P < 0.05 vs.
Vehicle), and cleaved caspase-1 (P < 0.05 vs. Vehicle) after
ICH. Moreover, the upregulation of IL-1β/IL-18 was also
attenuated by FeTPPS (P < 0.05 vs. Vehicle) (Fig. 12c–h).Fig. 12 Effects of FeTPPS on NLRP3 inflammasome activation and IL-1β/IL-
ICH, n = 6 rats per group (a). Western blot (d, b) showed that FeTPPS signi
the Vehicle group. Western blot assay (g) and quantification of NLRP3
IL-18 (j) after FeTPPS treatment 24 h following ICH, n = 5 rats per grou
protein apoptosis-associated speck-like protein containing a CARD, GAP
hemorrhage, IL interleukin, NLRP3 pyrin domain-containing 3, 3-NT 3-nitHowever, FeTPPS had no influence on P2X7R expressions
(Additional file 3). FeTPPS treatment significantly reduced
NLRP3 mRNA expression. Together, these results reveal
that P2X7R-dependent synthesis of ONOO− may be a key
activator of the NLRP3 inflammasome.Discussion
Innate immune and inflammatory responses are increas-
ingly recognized as important factors in the pathophysi-
ology of secondary brain injury following ICH. The NLRP3
inflammasome, the most characterized pattern recognition
receptor (PRR) in innate immune response initiation, is18 maturation. RT-PCR of NLRP3 after FeTPPS treatment 24 h following
ficantly reduced striatal 3-NT expression 24 h after ICH compared with
(c), ASC (e), caspase-1 p20 subunit (f), mature IL-1β (h), and mature
p. Data represent means ± SD. *P < 0.05, **P < 0.01. ASC adaptor
DH glyceraldehyde 3-phosphate dehydrogenase, ICH intracerebral
rotyrosine
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duces pro-inflammatory factors such as IL-1β [2].
Several distinct mechanisms have been proposed to ac-
count for NLRP3 activation, including potassium (K+) ef-
flux, intracellular calcium alteration, ubiquitination, and
reactive oxygen species (ROS) generation [36]. It was
recently reported that extracellular ATP-induced P2X7R
activation could directly mediate K+ efflux through the
hemichannel pannexin 1 to activate the NLRP3 inflamma-
some [5, 28, 36]. However, pannexin 1-deficient mice do
not show diminished caspase-1 activation [37], implying
that pannexin-1 is dispensable for the assembly of
caspase-1 activating inflammasome complexes. This raises
the hypothesis that other signaling pathways may be in-
volved in P2X7R-mediated NLRP3 inflammasome activa-
tion or that something besides pannexin 1 is necessary for
P2X7R-dependent K+ efflux. NOX2-derived ROS after
ATP release-mediated P2X7R activation is well established
in a growing body of in vitro and in vivo disease models
[23–25]. Importantly, there are a number of reports sup-
porting that high ROS levels, particularly NOX2-derived
ROS, are critical for NLRP3 inflammasome activation
[36]. RNS also play an important role as evidenced by the
fact that both an ONOO− scavenger and NOX2 inhibitor
suppressed nigericin-induced caspase-1 activation and IL-
1β secretion in human monocytes [28]. Additionally, K+
efflux can be positively regulated by ROS [14] and RNS
(e.g., ONOO−) [38]. In this regard, we propose that
NOX2-mediated ONOO− formation may link P2X7R and
NLRP3 inflammasome activation.
P2X7R activation in the ICH brain is a novel finding
of this study. ATP is released in large quantities follow-
ing any kind of cell injury [39], and cell death occurs 3
to 6 h after collagenase- induced ICH [40]. Elevated
extracellular ATP is necessary for P2X7R activation [13].
In the present study, increased P2X7R was observed as
early as 6 h after ICH in the perihematomal tissue along
with expression of the microglia marker Iba-1, suggest-
ing that P2X7R may act as a signal in the process of
microglia activation as previously reported [41].
Microglia are believed to be one of the first non-
neuronal cells to respond to brain injury [42], much earlier
than neutrophil invasion [43]. Activated microglia then re-
lease pro-inflammatory cytokines, such as IL-1β [44] and
IL-18 [45], which recruit leukocytes especially neutrophils.
The infiltrated neutrophils amplify neuroinflammation by
releasing and expressing neurotoxic factors or even by
stimulating microglia to secrete neurotoxic factors, creat-
ing a vicious cycle [46]. In the present study, upregulated
P2X7R was closely associated with increased NLRP3/ASC/
caspase-1 inflammasome expression; siRNA interference
or pharmacological blockage of P2X7R impaired inflam-
masome activation and IL-1β/IL-18 secretion, which had a
pronounced neuroprotective effect. Moreover, infiltratedneutrophils were also diminished in the BBG group com-
pared with the Vehicle group. These results indicate that
P2X7R may be responsible for ICH-induced inflammation,
possibly by NLRP3 inflammasome-dependent IL-1β/IL-18
release and subsequent neutrophil infiltration signals. In
accordance with our results, Ma and colleagues [2] found
that NLRP3 mainly colocalized with microglia but not with
other cell types, providing further support for a tight rela-
tionship between P2X7R and NLRP3.
In response to microglia activation, large amounts O2
−
and NO are released through activated NADPH oxidase
and iNOS [17], both of which play pivotal roles in ICH-
induced brain damage [15, 16]. In our study, enhanced
gp91phox in microglia largely colocalized with iNOS,
prompting us to consider ONOO−. Double IF revealed that
increased 3-NT was also expressed in microglia and mostly
overlapped with gp91phox. Consistently with this, Mander
and Brown [47] reported that activation of NOX or iNOS
alone was relatively harmless, but their simultaneous acti-
vation was lethal because it spurred ONOO− production.
Inhibition of either iNOS [48] or NOX2 [49] significantly
reduced ONOO− production in CNS disease models. Col-
lectively, we can infer that NOX2-derived O2
− and iNOS-
derived NO may contribute to ONOO− formation upon
microglia activation after ICH.
We also found that ICH-induced upregulations of
NOX2, iNOS, and ONOO− were diminished in BBG
treated ICH rats, indicating that they may be downstream
of P2X7R as previously reported [26, 29]. We next explored
the role of ONOO− in NLRP3 inflammasome activation.
As a highly active and relatively specific ONOO− decom-
position catalyst, FeTPPS exerts neuroprotective effects in
many CNS disease models [20, 50] because it catalyzes per-
oxynitrite to become a harmless nitrate [51]. Our results
show that overexpression of NLRP3 inflammasome compo-
nents and mature IL-1β/IL-18 was reduced by FeTPPS.
These findings suggest that ONOO− may be involved in
inflammasome activation following ICH. Consistent with
our results, an early report found that FeTPPS inhibited
nigericin-induced caspase-1 activation and IL-1β secretion
in human monocytes [28].
Although we did not attempt to explore the exact mech-
anisms of ONOO− in modulating NLRP3 inflammasome
activation, ONOO− may act as a key mediator for inflam-
masome activation through several mechanisms. Firstly,
direct oxidation of mitochondria and the release of mito-
chondrial DNA (mtDNA) activate the NLRP3 inflamma-
some; a recent study showed that oxidized mtDNA
released into the cytosol from injured mitochondria could
bind to and activate the NLRP3 inflammasome [52].
ONOO− is a potent ROS with strong abilities to oxidize
and nitrate proteins, lipids, and DNA. Mitochondria are a
primary target for peroxynitrite [18]. Secondly, nitration
can inactivate thioredoxin (Trx), leading to the
Feng et al. Journal of Neuroinflammation  (2015) 12:190 Page 15 of 17dissociation of thioredoxin interaction protein (TXNIP)
from Trx. Zhou et al. [53] reported that TXNIP could dis-
sociate from Trx in an ROS-sensitive way, allowing it to
bind and activate NLRP3. Thirdly, ONOO− may mediate
K+ efflux and then activate NLRP3. K+ efflux is a well-
characterized activator for NLRP3 inflammasome, and
ONOO− is a positive modulator for K+ efflux [38]. There-
fore, ONOO− may be responsible for NLRP3 inflamma-
some activation.
Of translational significance, we investigated the effect
of BBG in an ICH rat model. Previous studies have dem-
onstrated a neuroprotective effect of BBG in many acute
CNS diseases such as ischemic stroke [54], subarachnoid
hemorrhage [6], traumatic brain injury [55], and spinal
cord injury [56]. BBG is a derivative of the widely used
and Food and Drug Administration-approved food addi-
tive FD&C Blue number 1 [57]. With its low toxicity and
high selectivity, BBG is considered to be an attractive drug
for CNS diseases [56]. We found that BBG treatment
inhibited the inflammatory response via the P2X7R/
NLRP3 axis following ICH, and this was associated with
significantly improved neurological function and less brain
edema.
Several potential limitations deserve mention. Firstly,
although we employed the most commonly used ICH
model and injected sterile-filtered collagenase, the extra-
inflammatory responses induced by the collagenase itself
seemed unavoidable. Secondly, our observation period
was 72 h but it appears that ASC and caspase-1 activa-
tion may undergo a second peak at 72 h; we speculate
that other signaling pathways may be involved in ASC
and caspase-1 activation in a later phase. Finally, al-
though it was significant, the effect of P2X7R siRNA and
BBG on changes in brain water content and neurobehav-
ioral scores was relatively small. Thus, further experi-
ments are necessary to address these problems.Conclusion
In summary, our results indicate that P2X7R contributes
to NLRP3 inflammasome activation and subsequent IL-
1β/IL-18 release to drive brain inflammation and neuronal
damage in an ICH rat model. NOX2/iNOS-dependent
ONOO− formation, a potential downstream signaling
component of P2X7R, may be a key trigger of NLRP3
inflammasome activation. Thus, inhibition of P2X7R or
ONOO− could be a potential therapeutic target for sec-
ondary brain injury accompanying ICH.Additional files
Additional file 1: Experiment design and animal group classification.
ICH = intracerebral hemorrhage; WB = western blotting; BWC = brain water
content; IF = immunofluorescence; BBG = brilliant blue G. (TIFF 891 kb)Additional file 2: No evident immunostaining for P2X7R was found
in astrocytes and neurons. Double immunostaining showed that P2X7R
was not expressed in GFAP positive astrocytes (A). Double
immunostaining showed that P2X7R was not expressed in NeuN positive
neurons (B). (TIFF 4781 kb)
Additional file 3: FeTPPS treatment had no influence on P2X7R
expressions. Western blot (A,B) showed that FeTPPS did not affect the
protein expressions of P2X7R. *P < 0.05, **P < 0.01 (TIFF 494 kb)
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